Frontiers in Public Health (Jun 2022)

Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka

  • Diyanath Ranasinghe,
  • Deshni Jayathilaka,
  • Chandima Jeewandara,
  • Dumni Gunasinghe,
  • Dinuka Ariyaratne,
  • Tibutius Thanesh Pramanayagam Jayadas,
  • Heshan Kuruppu,
  • Ayesha Wijesinghe,
  • Fathima Farha Bary,
  • Deshan Madhusanka,
  • Pradeep Darshana Pushpakumara,
  • Dinuka Guruge,
  • Ruwan Wijayamuni,
  • Graham S. Ogg,
  • Gathsaurie Neelika Malavige,
  • Gathsaurie Neelika Malavige

DOI
https://doi.org/10.3389/fpubh.2022.873633
Journal volume & issue
Vol. 10

Abstract

Read online

BackgroundThe worst SARS-CoV-2 outbreak in Sri Lanka was due to the two Sri Lankan delta sub-lineages AY.28 and AY.104. We proceeded to further characterize the mutations and clinical disease severity of these two sub-lineages.Methods705 delta SARS-CoV-2 genomes sequenced by our laboratory from mid-May to November 2021 using Illumina and Oxford Nanopore were included in the analysis. The clinical disease severity of 440/705 individuals were further analyzed to determine if infection with either AY.28 or AY.104 was associated with more severe disease. Sub-genomic RNA (sg-RNA) expression was analyzed using periscope.ResultsAY.28 was the dominant variant throughout the outbreak, accounting for 67.7% of infections during the peak of the outbreak. AY.28 had three lineage defining mutations in the spike protein: A222V (92.80%), A701S (88.06%), and A1078S (92.04%) and seven in the ORF1a: R24C, K634N, P1640L, A2994V, A3209V, V3718A, and T3750I. AY.104 was characterized by the high prevalence of T95I (90.81%) and T572L (65.01%) mutations in the spike protein and by the absence of P1640L (94.28%) in ORF1a with the presence of A1918V (98.58%) mutation. The mean sgRNA expression levels of ORF6 in AY.28 were significantly higher compared to AY.104 (p < 0.0001) and B.1.617.2 (p < 0.01). Also, ORF3a showed significantly higher sgRNA expression in AY.28 compared to AY.104 (p < 0.0001). There was no difference in the clinical disease severity or duration of hospitalization in individuals infected with these sub lineages.ConclusionsTherefore, AY.28 and AY.104 appear to have a fitness advantage over the parental delta variant (B.1.617.2), while AY.28 also had a higher expression of sg-RNA compared to other sub-lineages. The clinical implications of these should be further investigated.

Keywords